Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity?


Autoria(s): Doggrell, Sheila
Data(s)

2005

Identificador

http://eprints.qut.edu.au/45111/

Publicador

Informa Healthcare

Relação

DOI:10.1517/14656566.6.12.2141

Doggrell, Sheila (2005) Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity? Expert Opinion on Pharmacotherapy, 6(12), pp. 2141-2144.

Palavras-Chave #060100 BIOCHEMISTRY AND CELL BIOLOGY #060500 MICROBIOLOGY #111500 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES
Tipo

Journal Article